This cluster randomized clinical trial assessed the effects of adding an internet-based weight loss intervention program to the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC program) on weight loss over 12 months among low-income, postpartum women.
This randomized clinical trial compares the effect of adding bevacizumab vs cetuximab to standard chemotherapy regimens on overall survival among patients with advanced or metastatic KRAS wild-type colorectal cancer.
This cohort study estimates age-specific risks of breast, ovarian, and contralateral breast cancer among carriers of BRCA1 and BRCA2 mutations and evaluates risk modification by family cancer history and location of the mutation within the BRCA gene.
This study uses NHANES data to assess trends in supplemental vitamin D intake of 1000 IU or more and 4000 IU or more daily between 1999 and 2014.
This Recommendation Statement from the US Preventive Services Task Force recommends that clinicians screen for obesity in children and adolescents 6 years and older and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight (B recommendation).
This Evidence Report and systematic review to support the 2017 US Preventive Services Task Force Recommendation Statement on screening for obesity summarizes current evidence on the benefits and harms of screening and treatment for obesity and overweight in children and adolescents.
This Viewpoint argues that abandoning opioids on principal may be premature and could harm patients successfully treating their chronic pain with opioids.
This Viewpoint advocates for reducing opioid misuse among primary care patients with chronic pain through a comprehensive approach emphasizing shared decision making, nonpharmacological treatments, nonopioid therapy, and a focus on functional improvement rather than pain elimination.
This Viewpoint discusses the best use of texting clinical information, noting that neither Health Insurance Portability and Accountability Act nor the Health Information Technology for Economic and Clinical Health Act offer specific guidelines.
This Viewpoint discusses bundled payment models and suggests ways in which the next generation of episode-based payments can better align with population health.
This JAMA Performance Improvement article uses the case of a patient with iatrogenic phenytoin toxicity due to an excess prescribed dosage to discuss proper handling and reporting of significant adverse drug events.
This Medical News article reveals how the food industry markets unhealthful products to kids.
Create a personal account or sign in to: